Original Article
Prospective Evaluation of the Safety and Feasibility of N-Butyl Cyanoacrylate Embolization
2023 Volume 14 Issue 1 Pages 31-37
Details
2023 Volume 14 Issue 1 Pages 31-37
Purpose: Several studies have reported the benefits of embolization with N-butyl cyanoacrylate (NBCA); however, few of them have been prospectively studied. This study aimed to prospectively evaluate the safety and feasibility of NBCA embolization, including cases of coagulopathy and/or unstable hemodynamics.
Materials and Methods: This study involved a sample of 20 cases treated with NBCA embolization. Cases were excluded from the study if other embolic substances were considered more suitable, if NBCA embolization was utilized for cerebral and coronary vessels, or if the operators determined that NBCA use was unsuitable.
Results: There were no cases of severe adverse events specific to NBCA and embolization was successful in all cases.
Conclusion: NBCA embolization is a safe and feasible treatment option, even for cases of coagulopathy and/or unstable hemodynamics.
